<DOC>
	<DOCNO>NCT02082899</DOCNO>
	<brief_summary>This Phase II Single Center , Randomized , Double-Masked , Vehicle-Controlled , Parallel , Group Study Assess Efficacy EBI-005 Topical Ophthalmic Solution Treatment Moderate Severe Allergic Conjunctivitis Using Environmental Exposure Chamber ( EEC ) Model Conjunctival Allergen Provocation Test ( CAPT ) Model . Approximately 150 subject enrol randomized one study center Canada duration 0.33 year .</brief_summary>
	<brief_title>A Single Center Study Treatment Moderate Severe Allergic Conjunctivitis ( EBI-005-AC-1 )</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>Provide write informed consent prior studyrelated procedure . Be 18 year age old . Have least 2 year history moderate severe allergic conjunctivitis . Have positive skin prick test ragweed within past 12 month Screening ( Visit 1A ) . Have score ≥ 2 staffassessed ocular redness least one region ( nasal temporal ) eye ≥ 2 subjectassessed ocular itching within 3.5hour period allergen exposure EEC Visit 1B . Have require one antiallergy pharmaceutical treatment past 2 year treat ocular symptom ( include oral , topical , nasal treatment ) . Be able selfadminister topical ophthalmic drop . Avoid topical systemic ocular medication entire study period . Are willing able follow instruction present require study visit duration study . Are female childbearing potential unwilling remain abstinent 30 day follow last dose study drug willing use acceptable birth control method . Have previously use IL1 blocker ( e.g. , Anakinra , Rilonacept , Ilaris ) . Have know contraindication hypersensitivity Anakinra ( Kineret® ) therapeutic agent target IL1 component study drug formulation . Current participation another clinical study involve experimental treatment participation study within 30 day prior study entry . Require concomitant use TNFblocking agent ( e.g. , Etanercept , Adalimumab , Infliximab ) . Have history glaucoma intraocular pressure ( IOP ) &gt; 25 mmHg Visit 1A ( Medical Screening ) history elevate IOP within past year . Have ocular surgery include laser procedure within past 12 month Visit 1A ( Medical Screening ) . Have contact lens wear within 4 week prior Visit 1A ( Medical Screening ) unwilling discontinue wear study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Allergic Conjunctivitis</keyword>
	<keyword>Interleukin 1 Receptor Inhibitor</keyword>
	<keyword>Environmental Exposure Chamber</keyword>
	<keyword>Conjunctival Allergen Provocation Test</keyword>
</DOC>